Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01801254 · ClinicalTrials.gov registry record · Phase 1

Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior

A Phase 1 study, sponsored by University of Rochester.

Completed
Registry status
Phase 1
Development phase
16
Enrollment target

NCT01801254 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01801254, a Phase 1 study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 1
Development phase
16 participants
Enrollment target

Study Summary

The field of neuroeconomics has begun to elucidate neural mechanisms underlying self-control; however, researchers have not yet harnessed neuroeconomics findings to develop interventions for improving self-control ability. The investigators are currently developing such an intervention. The investigators' approach involves using a brain-computer interface with audiovisual feedback to show people what is happening in their own brains, in real time. Through this interface, individuals are trained to increase levels of neural activity that may facilitate self-control, which, in turn, may improve the ability to exhibit self-controlled behaviors. This may increase the ability to engage in heath behaviors for which self-control is required (eg, dieting and exercising). The investigators' long-term goal is to create a tool that will help people develop the self-control needed to achieve lasting improvements in health behaviors.

Interventions

  • OTHER Sham Control
  • OTHER STRIDES

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2013-02
Est. Completion 2015-02
Phase Phase 1

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01801254

The ClinicalTrials.gov registry entry for NCT01801254 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham Control is the first listed.

NCT01801254 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01801254 about?

NCT01801254 is a clinical study titled "Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior". The field of neuroeconomics has begun to elucidate neural mechanisms underlying self-control; however, researchers have not yet harnessed neuroeconomics findings to develop interventions for improving self-control ability. The investigators are currently developing such an intervention. The investig...

What is the current status of trial NCT01801254?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2013-02. Estimated completion is 2015-02.

What interventions are being tested in trial NCT01801254?

The interventions under investigation include: Sham Control (OTHER), STRIDES (OTHER).

Who is sponsoring clinical trial NCT01801254?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.